The global companion animal diagnostics market is projected to grow from USD 2.99 billion in 2024 to USD 4.55 billion by 2029, registering a strong CAGR of 8.8%. The rise in pet ownership—particularly in developed regions such as North America and Europe—is a major driver of demand. Pets are increasingly viewed as family members, leading owners to invest heavily in preventive care, routine checkups, wellness programs, and advanced diagnostics.
This shift mirrors trends in human healthcare. Pet owners now expect the same quality of care for their animals, driving growth in services such as blood tests, imaging scans, genetic testing, and molecular diagnostics. The rapid expansion of veterinary hospitals and specialty clinics is further enabling access to high-quality diagnostic services.
However, the cost of advanced molecular diagnostics remains a barrier in low-income regions, limiting widespread adoption and posing a challenge to market growth.
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=173823870
In-depth TOC on “Companion Animal Diagnostics Market”
📌 528 Tables
📌 61 Figures
📌 422 Pages
Market Segmentation
1. By Product
- Consumables (largest share)
- Instruments
The consumables segment dominates the market due to the rising incidence of chronic and infectious diseases in pets—such as diabetes, parasitic infections, and cardiac disorders—which require routine and repeat diagnostic testing. Frequent monitoring encourages the continuous use of diagnostic reagents, rapid test kits, and related supplies.
2. By Animal Type
- Dogs (largest share)
- Cats
- Horses
- Other companion animals
Dogs constitute the largest share due to their higher susceptibility to conditions such as diabetes, cancer, infectious diseases, and cardiac disorders. Growing awareness among dog owners regarding early diagnosis and preventive care is accelerating the adoption of a wide range of diagnostic tools.
3. By Region
- North America (largest market in 2023)
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
- GCC Countries
North America leads the market owing to:
- High rates of pet ownership
- Strong veterinary infrastructure
- High awareness of pet health and wellness
- Significant demand for advanced diagnostic instruments
The US and Canada, in particular, have seen rising adoption of preventive diagnostic testing and wellness programs.
Request Sample Pages
https://www.marketsandmarkets.com/requestsampleNew.asp?id=173823870
Key Market Players
Major companies operating in the companion animal diagnostics market include:
*IDEXX (US), Zoetis Services LLC (US), Mars Incorporated (US), FUJIFILM Corporation (Japan), bioMérieux (France), Thermo Fisher Scientific (US), Virbac (France), Neogen (US), INDICAL BIOSCIENCE (Germany), IDvet (France), Randox Laboratories (UK), Mindray Animal Medical (China), Bionote USA, Boule (Sweden), EUROIMMUN (Germany), Biopanda (UK), Nova Biomedical (US), Megacor (Austria), Eurolyser (Austria), URIT Medical (China), Fassisi (Germany), Swissavans (Switzerland), Skyla Corporation (Taiwan), Ring Biotechnology (China), Alvedia (France).
Company Profiles
IDEXX (US)
IDEXX is a leading global provider of companion animal diagnostics, with a strong portfolio spanning diagnostic instruments, consumables, practice management software, and reference laboratory services. The company focuses heavily on innovation and strategic acquisitions.
- R&D expenditure in the Companion Animal Group increased from USD 140.6 million (2021) to USD 236.2 million (2022)—a 67.2% increase.
- IDEXX maintains premium pricing and continuous product enhancement to strengthen its competitive position.
Zoetis Services LLC (US)
Zoetis is a global leader in veterinary pharmaceuticals and diagnostics. Its growth strategy centers on developing new chemical, biological, and biopharmaceutical products, backed by a robust diagnostics division.
- R&D expenditure: USD 508M (2021) → USD 539M (2022) → USD 614M (2023)
- In May 2024, Zoetis launched Vetscan OptiCell, an AI-powered cartridge-based hematology analyzer for advanced CBC testing.
- Expanded international presence in Canada, Spain, Germany, Italy, Netherlands, Belgium, and Luxembourg in 2021.
Mars, Incorporated (US)
Mars, through its Petcare division, offers a wide array of veterinary and diagnostic services. The company has significantly expanded its capabilities through acquisitions and has built a strong global distribution network.
- Extensive presence across North America and 15+ countries
- Strong portfolio across veterinary care, diagnostics, and pet health services
- Strategic acquisitions enhance its diagnostic capabilities and reach
